Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Agnes  Klein, MD

Agnes Klein, MD

Senior Medical Advisor

Health Canada, Canada

Learning Objective : Identify various regulatory approaches in different international jurisdictions; Discuss a broad brush overview of diverse ways regulations can be approached; Explain the participation of Canada in international endeavors that will facilitate and improve the development of therapeutics.

Speaker(s)

Agnes  Klein, MD

International Collaborations in Clinical Trials

Agnes Klein, MD

Health Canada, Canada

Senior Medical Advisor

Marcin  Boruk, MBA, MSC

Orphan Drugs Regulations and Framework

Marcin Boruk, MBA, MSC

Health Canada, Canada

acting Director, Business Facilitation and Modernization Directorate, Health Can

Vicky Ann Hogan, PHD, MSC

Update on the Adoption and Implementation of ICH E2C (R2): Periodic Benefit-risk Evaluation Reporting in Canada

Vicky Ann Hogan, PHD, MSC

Health Canada, Canada

Manager, Blood Tissues and Organs Scientific Section

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.